Abstract
Intratracheal (i.t.) and intravenous (i.v.) delivery of DNA–vector formulations are two strategies to obtain gene transfer to the lung. It is still uncertain, however, which of these two modes of delivery will be more effective in the treatment of cystic fibrosis and other lung diseases. In this study, we attempted to optimize formulations of the cationic liposome DODAC:DOPE (dioleoyldimethylammonium- chloride:dioleoylphosphatidylethanolamine) complexed to plasmids encoding chloramphenicol acetyltransferase for i.t. and i.v. injection into CD-1 mice and compared the two methods. Our results showed that both methods conferred reporter gene expression in the lung that was significantly higher relative to injection of plasmid DNA alone. Expression using either mode of administration was maximal 24 h after injection and declined to around 10% of day 1 levels 2 weeks after injection. For i.v. delivery of DODAC: DOPE–DNA complexes multilamellar vesicles were more effective than large unilamellar vesicles in all organs investigated. Recombinant DNA could be detected in the distal lung region following either route of administration. However, i.t. administration predominantly led to DNA deposition in epithelial cells lining the bronchioles, eg in clara cells, whereas i.v. administration resulted in DNA deposition in the alveolar region of the lung including type II alveolar epithelial cells.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Griesenbach, U., Chonn, A., Cassady, R. et al. Comparison between intratracheal and intravenous administration of liposome–DNA complexes for cystic fibrosis lung gene therapy. Gene Ther 5, 181–188 (1998). https://doi.org/10.1038/sj.gt.3300562
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.gt.3300562
Keywords
This article is cited by
-
Intratracheal Versus Intravenous Liposomal Delivery of siRNA, Antisense Oligonucleotides and Anticancer Drug
Pharmaceutical Research (2009)
-
Endostatin gene therapy on murine lung metastases model utilizing cationic vector-mediated intravenous gene delivery
Gene Therapy (2003)
-
"Bronchial Artery Delivery of Viral Vectors for Gene delivery in Cystic Fibrosis; Superior to Airway Delivery?"
BMC Pulmonary Medicine (2002)
-
Delivery Systems for Pulmonary Gene Therapy
American Journal of Respiratory Medicine (2002)
-
Mechanism of lipoplex gene delivery in mouse lung: binding and internalization of fluorescent lipid and DNA components
Gene Therapy (2001)